SilverSun Technologies Inc
Change company Symbol lookup
Select an option...
SSNT SilverSun Technologies Inc
MDLZ Mondelez International Inc
FE FirstEnergy Corp
CADE Cadence Bancorp
SCHD Schwab U.S. Dividend Equity ETF™
ARKK ARK Innovation ETF
URANF International Prospect Ventures Ltd
QSR Restaurant Brands International Inc
STAF Staffing 360 Solutions Inc
BOKF BOK Financial Corp
Go

Information Technology : Software | Small Cap Blend
Company profile

SilverSun Technologies, Inc. is a business application, technology and consulting company. The Company is engaged in providing strategies and solutions to meet information, technology and business management needs. Its services and technologies enable customers to manage, protect and monetize their enterprise assets in the cloud. It offers solutions for accounting and business management, financial reporting, enterprise resource planning (ERP), warehouse management systems (WMS), human capital management (HCM), customer relationship management (CRM) and business intelligence (BI). The Company has dedicated Information Technology (IT) network services practice that provides managed services, cybersecurity, application hosting, disaster recovery, business continuity, cloud and other services. Its customers are across the United States, with concentrations in the New York/New Jersey metropolitan area, Arizona, Southern California, North Carolina, Washington, Oregon and Illinois.

Closing Price
$6.35
Day's Change
0.11 (1.76%)
Bid
--
Ask
--
B/A Size
--
Day's High
6.38
Day's Low
6.20
Volume
(Light)
Volume:
39,613

10-day average volume:
213,724
39,613

Bionano Genomics shares fall after plan to sell more stock

4:48 pm ET January 7, 2021 (MarketWatch)
Print

Bionano Genomics Inc. (BNGO) plans to sell more shares after a sudden surge in its stock price in recent weeks, and shares dove in after-hours trading Thursday in response. The company revealed Thursday afternoon that it expects to sell more shares under a shelf prospectus filed in August, but did not spell out how many shares it plans to sell nor at what price. The genome-analysis company's shares traded for less than $1 for much of 2020, but began to move sharply higher around Christmas, gaining more than 800% in the past month. Shares closed Thursday at $5, a retreat from highs topping $7 earlier in the week, then fell more than 10% in after-hours trading Thursday following the news that more shares would be sold.

-Jeremy C. Owens; 415-439-6400; AskNewswires@dowjones.com

	

(END) Dow Jones Newswires

January 07, 2021 16:48 ET (21:48 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.